journal cover

Change in multiple sclerosis prevalence over time in Australia 2010-2017 utilising disease-modifying therapy prescription data

Multiple Sclerosis : Clinical and Laboratory Research

Jul 26, 2019

Julie Ann CampbellAndrew J. Palmer

Get paper from

Abstract

Determine the prevalence of multiple sclerosis (MS) in Australia in 2017 using MS-specific disease-modifying therapy (DMT) prescription data and estimate the change in prevalence from 2010. DMT prescriptions were extracted from Australia's Pharmaceutical Benefits Scheme (PBS) data for J...read more

Mentioned in this Paper

Longitudinal Studies
Multiple Sclerosis
N, N-Dimethyltryptamine
Persons
Prescription Procedure
Regression Analysis
Mass Spectrometry
Australian
alemtuzumab
DMT Dependence
1
3

Change in multiple sclerosis prevalence over time in Australia 2010-2017 utilising disease-modifying therapy prescription data

Multiple Sclerosis : Clinical and Laboratory Research

Jul 26, 2019

Julie Ann CampbellAndrew J. Palmer

PMID: 31347952

DOI: 10.1177/1352458519861270

Abstract

Determine the prevalence of multiple sclerosis (MS) in Australia in 2017 using MS-specific disease-modifying therapy (DMT) prescription data and estimate the change in prevalence from 2010. DMT prescriptions were extracted from Australia's Pharmaceutical Benefits Scheme (PBS) data for J...read more

Mentioned in this Paper

Longitudinal Studies
Multiple Sclerosis
N, N-Dimethyltryptamine
Persons
Prescription Procedure
1
3

Related Papers

Get paper from

/papers/change-in-multiple-sclerosis-prevalence-over-time/31347952